HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peng Xie Selected Research
Peng Xie Research Topics
Disease
49
Neoplasms (Cancer)
12/2022 - 05/2008
35
Major Depressive Disorder (Major Depressive Disorders)
01/2022 - 04/2012
24
Infections
01/2022 - 08/2006
19
Inflammation (Inflammations)
06/2022 - 10/2014
15
Neoplasm Metastasis (Metastasis)
01/2022 - 03/2010
12
Schizophrenia (Dementia Praecox)
01/2022 - 07/2014
12
Glioma (Gliomas)
01/2020 - 01/2014
11
Stroke (Strokes)
11/2022 - 03/2015
9
Depressive Disorder (Melancholia)
01/2022 - 06/2006
9
Bipolar Disorder (Manic Depressive Psychosis)
02/2021 - 01/2014
9
Treatment-Resistant Depressive Disorder
01/2020 - 12/2013
8
Reperfusion Injury
12/2022 - 01/2016
8
Hypoxia (Hypoxemia)
12/2022 - 01/2016
8
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 02/2012
7
Body Weight (Weight, Body)
08/2022 - 04/2013
7
Ischemic Stroke
02/2020 - 07/2008
7
Carcinoma (Carcinomatosis)
11/2019 - 12/2010
7
Nasopharyngeal Carcinoma
08/2019 - 06/2010
6
Lung Neoplasms (Lung Cancer)
09/2021 - 11/2015
5
Ischemia
01/2022 - 06/2010
5
Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 10/2020
5
Glioblastoma (Glioblastoma Multiforme)
08/2021 - 11/2015
5
Brain Ischemia (Cerebral Ischemia)
12/2020 - 03/2009
5
Virus Diseases (Viral Diseases)
06/2019 - 01/2012
4
Dysbiosis
10/2022 - 10/2020
4
Hemorrhage
09/2022 - 06/2010
4
Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2022 - 03/2018
4
Hepatocellular Carcinoma (Hepatoma)
06/2022 - 01/2017
4
Pain (Aches)
03/2022 - 01/2020
4
Cerebral Hemorrhage
03/2022 - 11/2012
4
Carcinogenesis
01/2022 - 01/2017
4
Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 01/2016
4
Congenital Abnormalities (Deformity)
12/2021 - 07/2015
4
Esophagitis
05/2021 - 01/2014
4
Mental Disorders (Mental Disorder)
01/2021 - 01/2015
4
Melanoma (Melanoma, Malignant)
01/2021 - 06/2009
4
Pathologic Constriction (Stenosis)
07/2020 - 12/2014
4
Chronic Renal Insufficiency
11/2019 - 01/2013
3
Heart Failure
12/2022 - 01/2021
3
Hyperglycemia
03/2022 - 01/2020
3
Dyslipidemias (Dyslipidemia)
01/2022 - 02/2021
3
Myocardial Infarction
01/2022 - 01/2017
3
Anhedonia
01/2022 - 05/2016
3
Weight Gain
01/2022 - 02/2021
3
Breast Neoplasms (Breast Cancer)
06/2021 - 05/2015
3
Hypertension (High Blood Pressure)
01/2020 - 04/2010
3
Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 01/2012
3
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020 - 01/2017
3
Osteoarthritis
01/2020 - 01/2019
3
Alzheimer Disease (Alzheimer's Disease)
07/2019 - 03/2013
Drug/Important Bio-Agent (IBA)
31
Proteins (Proteins, Gene)
FDA Link
01/2022 - 09/2014
29
Biomarkers (Surrogate Marker)
IBA
06/2022 - 01/2013
16
Antidepressive Agents (Antidepressants)
IBA
01/2021 - 01/2013
15
MicroRNAs (MicroRNA)
IBA
03/2022 - 12/2010
11
Lipids
IBA
10/2022 - 05/2008
10
Pharmaceutical Preparations
IBA
01/2022 - 07/2015
10
Messenger RNA (mRNA)
IBA
01/2021 - 06/2014
9
RNA (Ribonucleic Acid)
IBA
03/2022 - 08/2014
9
Biological Products
IBA
01/2022 - 05/2015
8
Phosphotransferases (Kinase)
IBA
01/2022 - 05/2008
7
Antipsychotic Agents (Antipsychotics)
IBA
01/2022 - 01/2013
7
Long Noncoding RNA
IBA
01/2021 - 06/2016
6
Tissue Plasminogen Activator (Alteplase)
FDA Link
11/2022 - 03/2009
6
Interleukin-6 (Interleukin 6)
IBA
12/2020 - 09/2011
6
Sevoflurane (Ultane)
FDA Link
Generic
01/2020 - 01/2016
6
Catenins
IBA
01/2020 - 08/2012
5
Amino Acids
FDA Link
10/2022 - 01/2012
5
Cisplatin (Platino)
FDA Link
Generic
06/2022 - 10/2019
5
Sucrose (Saccharose)
IBA
01/2022 - 05/2016
5
Platinum
IBA
12/2021 - 10/2017
5
Neuroprotective Agents
IBA
01/2019 - 03/2009
4
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
08/2022 - 04/2010
4
Cytokines
IBA
06/2022 - 01/2020
4
Glucose (Dextrose)
FDA Link
Generic
03/2022 - 07/2015
4
Olanzapine (Zyprexa)
FDA Link
01/2022 - 04/2015
4
Antiviral Agents (Antivirals)
IBA
01/2022 - 12/2014
4
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
06/2015 - 06/2010
4
Antibodies
IBA
03/2015 - 09/2009
3
Calcium-Calmodulin-Dependent Protein Kinase Type 2
IBA
12/2022 - 01/2021
3
Therapeutic Uses
IBA
06/2022 - 01/2018
3
Type A Botulinum Toxins (Botox)
FDA Link
02/2022 - 01/2019
3
Neurotransmitter Agents (Neurotransmitter)
IBA
01/2022 - 01/2018
3
Glutamic Acid (Glutamate)
FDA Link
01/2022 - 06/2012
3
ErbB Receptors (EGF Receptor)
IBA
12/2021 - 01/2016
3
Lysine (L-Lysine)
FDA Link
01/2021 - 09/2014
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2020 - 11/2016
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2020 - 01/2017
3
Interleukin-10 (Interleukin 10)
IBA
01/2020 - 11/2015
3
Adenosine Triphosphate (ATP)
IBA
01/2020 - 06/2012
3
Circular RNA
IBA
01/2020 - 01/2017
3
Solutions
IBA
01/2020 - 01/2014
3
Acids
IBA
11/2019 - 01/2013
3
Analgesics (Analgesic Drugs)
IBA
10/2019 - 03/2010
3
Matrix Metalloproteinases (MMPs)
IBA
08/2019 - 02/2016
Therapy/Procedure
37
Therapeutics
12/2022 - 03/2009
13
Drug Therapy (Chemotherapy)
01/2022 - 01/2014
13
Radiotherapy
01/2022 - 03/2009
6
Chemoradiotherapy
01/2020 - 01/2014
5
Aftercare (After-Treatment)
11/2022 - 07/2011
3
Conservative Treatment
01/2021 - 11/2015